Bafna Pharmaceuticals Limited Cash Flow Conversion Efficiency

Latest as of September 2025: 0.102x

Bafna Pharmaceuticals Limited cash flow conversion efficiency. Based on the latest financial reports, Bafna Pharmaceuticals Limited (BAFNAPH) has a cash flow conversion efficiency ratio of 0.102x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs93.12 Million ≈ $1.01 Million USD) by net assets (Rs912.28 Million ≈ $9.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Bafna Pharmaceuticals Limited (2005–2026)

Cash flow conversion efficiency of Bafna Pharmaceuticals Limited from 2005 to 2026. This chart illustrates how Bafna Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Bafna Pharmaceuticals Limited for real-time trading data and today's change.

Bafna Pharmaceuticals Limited Cash Flow Conversion Ratio Explained

Bafna Pharmaceuticals Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Bafna Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bafna Pharmaceuticals Limited ranked by their cash flow conversion efficiency. Also see market value of Bafna Pharmaceuticals Limited for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Apiam Animal Health Ltd AU:AHX	0.076x
STIF Société anonyme PA:ALSTI	-0.068x
Answear.com S.A. WAR:ANR	-0.093x
Atomera Inc NASDAQ:ATOM	-0.175x
Kulmbacher Brauerei Aktien-Gesellschaft MU:KUL	0.001x
Gabelli Global Utility & Income Tr NYSE MKT:GLU	N/A
Cashbil JSE:CSB	0.225x
INNATE PHARMA SP.ADR/1 F:IDDA	N/A

Annual Cash Flow Conversion Efficiency for Bafna Pharmaceuticals Limited (2005–2026)

The table below shows the annual cash flow conversion efficiency of Bafna Pharmaceuticals Limited from 2005 to 2026. Review Bafna Pharmaceuticals Limited free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-03-31	Rs1.00 Billion ≈ $10.83 Million	Rs118.27 Million ≈ $1.28 Million	0.118x	-48.72%
2025-03-31	Rs848.07 Million ≈ $9.17 Million	Rs195.29 Million ≈ $2.11 Million	0.230x	+96.27%
2024-03-31	Rs808.39 Million ≈ $8.74 Million	Rs94.85 Million ≈ $1.03 Million	0.117x	+74.02%
2023-03-31	Rs734.55 Million ≈ $7.94 Million	Rs49.52 Million ≈ $535.59K	0.067x	-57.06%
2022-03-31	Rs619.64 Million ≈ $6.70 Million	Rs97.28 Million ≈ $1.05 Million	0.157x	+165.49%
2021-03-31	Rs567.71 Million ≈ $6.14 Million	Rs-136.09 Million ≈ $-1.47 Million	-0.240x	+64.19%
2020-03-31	Rs511.95 Million ≈ $5.54 Million	Rs-342.68 Million ≈ $-3.71 Million	-0.669x	-606.06%
2019-03-31	Rs188.52 Million ≈ $2.04 Million	Rs-17.87 Million ≈ $-193.28K	-0.095x	+49.95%
2018-03-31	Rs372.02 Million ≈ $4.02 Million	Rs-70.47 Million ≈ $-762.14K	-0.189x	-742.20%
2017-03-31	Rs421.12 Million ≈ $4.55 Million	Rs-9.47 Million ≈ $-102.44K	-0.022x	-242.15%
2016-03-31	Rs575.71 Million ≈ $6.23 Million	Rs9.11 Million ≈ $98.52K	0.016x	-89.21%
2015-03-31	Rs727.13 Million ≈ $7.86 Million	Rs106.65 Million ≈ $1.15 Million	0.147x	+536.93%
2014-03-31	Rs697.48 Million ≈ $7.54 Million	Rs16.06 Million ≈ $173.70K	0.023x	-95.71%
2013-03-31	Rs683.04 Million ≈ $7.39 Million	Rs366.32 Million ≈ $3.96 Million	0.536x	+460.94%
2012-03-31	Rs646.17 Million ≈ $6.99 Million	Rs-96.01 Million ≈ $-1.04 Million	-0.149x	-26.74%
2011-03-31	Rs541.89 Million ≈ $5.86 Million	Rs-63.53 Million ≈ $-687.07K	-0.117x	-708.49%
2010-03-31	Rs410.05 Million ≈ $4.43 Million	Rs-5.95 Million ≈ $-64.31K	-0.015x	+96.00%
2009-03-31	Rs385.23 Million ≈ $4.17 Million	Rs-139.82 Million ≈ $-1.51 Million	-0.363x	-105.51%
2008-03-31	Rs118.55 Million ≈ $1.28 Million	Rs-20.94 Million ≈ $-226.43K	-0.177x	-115.97%
2007-03-31	Rs91.39 Million ≈ $988.34K	Rs101.06 Million ≈ $1.09 Million	1.106x	+1151.53%
2006-03-31	Rs56.78 Million ≈ $614.05K	Rs-5.97 Million ≈ $-64.57K	-0.105x	+83.71%
2005-03-31	Rs42.55 Million ≈ $460.13K	Rs-27.46 Million ≈ $-297.02K	-0.646x	--

About Bafna Pharmaceuticals Limited

NSE:BAFNAPH India Drug Manufacturers - Specialty & Generic

Market Cap

$116.28 Million

Rs10.75 Billion INR

Market Cap Rank

#18377 Global

#992 in India

Share Price

Rs454.50

Change (1 day)

+1.55%

52-Week Range

Rs99.16 - Rs470.55

All Time High

Rs507.50